RhinoCare
Heat Therapy Device for Treating Sinus Congestion
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in December 2014 by Dan Shaham, RhinoCare operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its medical device technology.
Business overview
RhinoCare is a medical device company focused on respiratory solutions, specifically developing devices for treating sinus congestion. Its core product, RhinoTherm, is an inhaler that utilizes hyperthermia technology from the Weizmann Institute of Science to relieve nasal congestion symptoms. The company operates within the Health Tech & Life Sciences sector, serving the medical devices, medical treatment, and drug delivery markets.
Log in to access full profile ›Company Intelligence Q&A
- What is RhinoCare's primary focus?
- RhinoCare is a medical device company specializing in respiratory solutions, particularly for treating sinus congestion.
- Who founded RhinoCare?
- RhinoCare was founded by Dan Shaham in December 2014.
- What is the core technology behind RhinoCare's product?
- RhinoCare's RhinoTherm device uses hyperthermia technology, developed at the Weizmann Institute of Science, to alleviate nasal congestion symptoms.
- What stage is RhinoCare currently in?
- RhinoCare is currently in the Pre-Funding stage, with its product in the R&D phase.
- What markets does RhinoCare target?
- RhinoCare targets the medical devices, medical treatment & therapeutics, and drug delivery markets within the healthcare sector.